Mizuho Securities Initiates Sabra Health Care With Neutral

Analysts at Mizuho Securities initiated coverage on

with a Neutral rating. The target price for Sabra Health Care is set to $27. Sabra Health Care shares have dropped 8.03 percent over the past 52 weeks, while the S&P 500 index has surged 4.63 percent in the same period. Sabra Health Care shares rose 1.01 percent to close at $26.00 yesterday.